Global Histology and Cytology Market 2022 Overview, Key Players, Segmentation Analysis, Development Status and Forecast by 2030

SDKI Inc. published a new report on the Global Histology and Cytology Market-Forecast 2022-2030. This study includes the statistical and analytical approaches needed to grow the histology and cytology markets. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-59125

The histology and cytology market is estimated to reach US $ 39.07 billion by 2030 from a market value of US $ 16.10 billion in 2022 and is expected to grow at a CAGR of 13.5% during the 2022-2030 forecast period. I am.

Histology and cytology are scientific related to the diagnosis of diseases and other conditions. I am a specialist. Histology is the study of microscopic anatomy of cells and human tissues, including structure and function. Cytology, on the other hand, is a branch of life science and is emphasized in the study of human cells in terms of function, structure and chemistry. Related tests are performed by placing contaminated tissue or cell samples in an electron microscope or light microscope. This allows scientists to examine the microscopic anatomy of the sample.

Sample URL for the report
https://www.sdki.jp/sample-request-59125

Increasing prevalence of cancer and technological advances in diagnostic and molecular technology are key drivers of the growth of the histology and cytology markets. Increasing standardization of pathological laboratories and favorable reimbursement for cancer screening and clinical testing have also contributed to the growth of the histology and cytology markets during the forecast period. According to the International Agency for Research on Cancer (IARC), there are approximately 17 million new cancer cases worldwide and 9.5 million cancer deaths registered in 2018. In addition, the global burden of cancer is expected to extend to approximately 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This is accelerating the demand for histology and cytology and is expected to contribute to the growth of the global histology and cytology market. However, safety and diagnostic accuracy issues, and the lack of public awareness of diagnostic tests, may impede the growth of the histology and cytology markets during the 2022-2030 forecast period.

Histology and Cytology Market Segment

The histology and cytology market is divided by test type (histology, cytology), product (equipment and analysis software system, consumables and reagents), end user (life science, clinical diagnostics), and region. Will be done. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview

The histology and cytology market The histology and cytology market is further subdivided based on region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

North America is the world's leading region in terms of market share. This is due to the increased incidence of cancer, favorable government reimbursement policies, and the availability of advanced medical infrastructure in the region. Meanwhile, the Asia-Pacific histology and cytology markets are expected to show the highest growth rate / CAGR during the 2022-2030 forecast period. This is due to an increase in the elderly population, increased cancer incidence, and increased awareness of cancer screening in developing countries such as India and China.

Details of the research report
https://www.sdki.jp/press-details/global-histology-and-cytology-market/53

A key player in the histology and cytology markets

Key players in the histology and cytology market include Hologic, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., These include Sysmex Corporation, Trivitron Healthcare and Koninklijke Philips NV. The study includes a detailed competitive analysis of these major companies in the histology and cytology markets, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.